US Broker Ratings

Adaptive Biotechnologies (ADPT) Stock Analysis: Evaluating a 15% Upside Potential in the Healthcare Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering force in the healthcare sector, stands at the forefront of immune medicine innovation with its cutting-edge diagnostics and research..

Amphastar Pharmaceuticals (AMPH) Investor Outlook: Analyzing Growth Potential Amidst a Mixed Analyst Consensus

Investors eyeing Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) should be prepared for a complex landscape of opportunity and risk as this biopharmaceutical firm continues to navigate the..

Neogen Corporation (NEOG) Investor Outlook: Analyzing the 14.66% Potential Upside in Medical Devices

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector specializing in medical devices, continues to capture investor attention with a notable 14.66% potential upside..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 58.71% Potential Upside in Biotech Innovations

Biohaven Ltd. (NASDAQ: BHVN) stands at the intersection of innovation and opportunity within the biotechnology sector. With a market capitalization of $2.18 billion, this U.S.-based healthcare..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 45.7% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector within the specialty and generic drug manufacturing industry, is drawing significant attention from investors...

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Biotech with 293% Upside Potential

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a notable player in the biotechnology sector, has recently captured the attention of investors with its remarkable potential upside. Specializing in..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 46.89% Potential Upside for Savvy Investors

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is a key player in the healthcare sector, specifically within the medical devices industry. The San Diego-based company has made..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth with a 12% Revenue Surge

For investors keeping an eye on the healthcare sector, Azenta, Inc. (NASDAQ: AZTA) presents a nuanced opportunity. With its focus on providing biological and chemical compound..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 84% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) stands out in the biotechnology sector with a compelling potential upside of 84.25%, making it a noteworthy consideration for investors seeking..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A Closer Look at Its Growth Potential and Analyst Ratings

Healthcare Services Group, Inc. (NASDAQ: HCSG), a prominent player in the healthcare sector, offers a suite of essential management and operational services to medical care facilities..

NewAmsterdam Pharma (NAMS) Stock Analysis: Unveiling a 154.62% Potential Upside in Biotech Innovation

NewAmsterdam Pharma Company N.V. (NAMS), headquartered in Naarden, the Netherlands, is a promising player in the biotechnology sector, focusing on innovative therapies for cardiometabolic and neurological..

NeoGenomics, Inc. (NEO) Stock Analysis: A 30% Upside Potential in the Healthcare Diagnostics Arena

For investors scouting opportunities in the healthcare sector, NeoGenomics, Inc. (NASDAQ: NEO) presents a compelling case with a potential upside of nearly 31%. Positioned at the..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 23% Upside Potential and Robust Growth in Dermatological Treatments

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) has positioned itself as a noteworthy player within the biotechnology sector, focusing on innovative treatments for dermatological conditions. With its market..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: High Potential with a 9.42% Upside

For investors seeking opportunities in the healthcare sector, U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing prospect. The company, operating within the medical care facilities..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A 27% Potential Upside Beckons Investors

For investors eyeing opportunities in the healthcare sector, Guardian Pharmacy Services, Inc. (GRDN) stands out with a compelling potential upside of 27.22%. This Atlanta-based company is..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a 66% Upside Potential for Investors

Innoviva, Inc. (NASDAQ: INVA), a pivotal player in the biotechnology sector, is catching the attention of investors with its noteworthy performance metrics and promising financial outlook...

Integra LifeSciences Holdings (IART) Stock Analysis: Evaluating the 34% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a prominent player in the medical devices industry, operating within the broader healthcare sector. Based in the United States,..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Navigating a 19.71% Downside Amidst Promising Revenue Growth

BioLife Solutions, Inc. (NASDAQ: BLFS) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Bothell, Washington, the..

Wave Life Sciences, Inc. (WVE) Stock Analysis: A Biotech Gem with a 450% Potential Upside

Wave Life Sciences, Inc. (NASDAQ: WVE) is capturing investor attention with a compelling story in the biotechnology sector. With a market capitalization of $632.52 million, this..

PACS Group, Inc. (PACS) Stock Analysis: Strong Buy Ratings and 21% Upside Potential Highlight Investor Appeal

Investors seeking growth opportunities in the healthcare sector may find PACS Group, Inc. (PACS) particularly compelling. As a dominant player in the medical care facilities industry,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds